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Abstract
Proteinase-activated receptor 2 (PAR-2), activated by trypsin and other serine proteinases, is a key
initiator of inflammatory responses in the intestine of mammals. Atlantic salmon fed diets with
standard qualities of soybean meal (SBM) show enteritis of the distal intestine as well as increased
activity of trypsin in both luminal contents and wall tissue. Luminal trypsin activity may possibly be
involved in immune related disorders of the intestine also in Atlantic salmon via activation of PAR
2. In the present study our aim was to investigate if PAR-2 play a role in SBM induced enteritis. We
performed multiple alignments based on nucleic acid sequences of PAR-2 from various animals
available from public databases, and designed primers for use in cloning of the Atlantic salmon PAR-
2 transcript. We further cloned and characterized the full length sequence of Atlantic salmon PAR-
2 and investigated the expression in both early and chronic stages of SBM induced enteropathy.
Two full length versions of PAR-2 cDNA were identified and termed PAR-2a and PAR-2b.
Expression of the two PAR-2 transcripts was detected in all 18 tissues examined, but most
extensively in the intestine and gills. A significant up-regulation in the distal intestine was observed
for the PAR-2a transcript after 1 day feeding diets containing SBM. After 3 weeks of feeding, PAR-
2a was down-regulated compared to the fish fed control diets. These findings may indicate that
PAR-2a participates in inflammatory responses in both the early and later stages of the SBM
enteropathy. In the chronic stages of the enteropathy, down-regulation of PAR-2a may indicate a
possible desensitization of the PAR-2a receptor. Expression of PAR-2b was not altered in the first
7 days of SBM feeding, but a significant up regulation was observed after 3 weeks, suggesting a
putative role in chronic stages of SBM induced enteritis. The expression differences of the two
PAR-2 transcripts in the feed trials may indicate that they have different roles in the SBM induced
enteritis.
Introduction
By ingesting feed, the gastrointestinal tract (GI tract) is
presented to food components and microorganisms car-
ried with the feed exposing the organism to allergens and
pathogens that can cause disease and hence affect animal
welfare. The GI tract is one of a few major entry points for
microorganisms and pathogens, and hence, animals have
well developed physical and chemical barriers in combi-
nation with an effective mucosal immune system [1]. The
mucosal and chemical barriers can be breached by micro-
organisms and pathogens, and once breached, circulating
innate immune cells will form a second important basis
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for defence. The gut immune apparatus represents there-
fore a major element in the defence of an animal, and is
considered the largest immunological organ in man [2]. A
well functioning immune apparatus in the gastrointesti-
nal tract is therefore of utmost importance for the func-
tion and wellbeing of all animals.
SBM induced enteritis
Standard qualities of soybean meal (SBM), the most
important and cheapest protein rich feedstuff on the
world market, can only be used at limited levels in salmo-
nid diets because it challenges the gut immune systems
and fish health. Salmon, when fed diets with standard
qualities of SBM develop an inflammation like condition
(enteritis) in the distal intestine characterized by inflam-
matory infiltrate in the intestinal mucosa, atrophy of pri-
mary and secondary mucosal folds and decrease of
epithelial vacuolization [3-5]. A previous study investigat-
ing the development of the enteritis using a 33% SBM feed
showed minor changes in intestinal histology in some of
the samples after two days of feeding [3]. After 7 days of
feeding SBM the fish displayed all the signs present in the
fully developed condition including increased width and
marked reduction in height of simple mucosal folds as
well as increased cell infiltration of the lamina propria [3].
Further, upon feeding SBM for 14–21 days the enteritis
was fully developed in all the fish examined [3]. The SBM
induced enteritis may also be a key factor in the decrease
in growth as well as nutrient digestibility and absorption
observed at higher inclusion levels [6-9] and has been sug-
gested to have a negative effect on disease resistance [10].
Salmonids fed diets with standard qualities of SBM show
elevated activity of trypsin-like enzymes [11,12] suggest-
ing that trypsin might be involved in the development of
SBM induced enteritis. Further, studies with partly frac-
tionated soybean extracts have shown that the feed sub-
stances participating in the enteropathy in salmon are
soluble in alcohol [13,14]. Later studies has suggested that
saponins, present in the soy alcohol extract, is a com-
pound that may cause some, but not all, of the intestinal
alterations seen in Atlantic salmon fed soybean meal [15].
Saponins are known to increase permeability of intestinal
tissue and thereby increase exposure to immune stimu-
lants [16]. But still, more than 18 years after the SBM
induced enteritis was reported, the causative molecular
agents present in SBM responsible for the pathogenesis
have not been identified.
PAR-2 receptors and inflammation
Several studies in mammalian species have shown that
activation of cell surface receptors termed proteinase-acti-
vated receptors (PARs) are key activators of inflammatory
responses in a wide range of tissues including the gastroin-
testinal tract (GI) and airways [17-23]. These cell surface
receptors are G-protein coupled and belongs to a family of
seven transmembrane receptors that can be activated by
serine proteinases, such as trypsin. So far, four proteinase-
activated receptors have been cloned and studied in man
[24-27], but to our knowledge no proteinase-activated
receptors have been studied in teleost fish. Activation of
PAR-2 (proteinase-activated receptor 2) in mammals is
achieved by proteolytic cleavage of an extracellular pep-
tide sequence hereby exposing an N-terminal tethered lig-
and domain that binds to and activates the receptor
[28,29]. Upon activation of the PAR-2 receptor in mam-
mals, the receptor is internalized and targeted to lyso-
somes for degradation [30,31]. To resensitize the cells
from the irreversible receptor cleavage new receptors are
mobilized by large Golgi stores as well as synthesis of new
receptors [30]. The PAR-2 receptor has been detected in
various diverse tissues such as brain, eye, airway, heart, GI
tract, pancreas, kidney, liver, prostate, skin and in cells
such as epithelial cells, endothelial cells, as well as in
immune cells such as T-cells, neutrophils, mast cells and
eosinophils [32,33]. Some of the PAR-2 mediated effects
on leukocytes involve leukocyte rolling and adhesion [34]
as well as leukocyte migration in vivo [35]. Activation of
PAR-2 by serine proteinases have been shown, in vitro, to
stimulate bone marrow progenitor cells to develop into
dendritic cells [36]. Hence, serine proteinases might par-
ticipate in adaptive immune responses in vivo. Activation
of PAR-2 by trypsin in luminal colonocytes in mice affect
the permeability and hence could play an important role
in pathogenesis of different mammalian gastrointestinal
disorders [22]. In humans, elevated colonic luminal ser-
ine proteinase activity of irritable bowels syndrome (IBS)
patients has been suggested to involve PAR-2 activation
and mediate epithelial barrier dysfunction and pathogen-
esis of IBS [37].
Mechanisms of immune responses in fish, whether stim-
ulated by dietary components or pathogens are not well
described. A better understanding of these responses is
expected to lead the way to develop healthier and more
productive diets and found the basis for improvements in
disease prevention and treatments.
The reported importance of PAR-2 activation in mamma-
lian inflammatory diseases motivated the cloning,
sequencing and expression analysis of the PAR-2 tran-
script in Atlantic salmon fed SBM diets. The data pre-
sented indicates a possible role of PAR-2 as a mediator of
inflammatory responses in the distal intestine of Atlantic
salmon.
Materials and methods
Experimental animals
In order to study the impact of diets containing SBM on
the mRNA expression of PAR-2, samples from both aJournal of Inflammation 2008, 5:18 http://www.journal-inflammation.com/content/5/1/18
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short term trial (1–7 days) and a long term trial (21 days)
were collected.
Short term trial
Farmed Atlantic salmon (Salmobreed strain), weighing
214 g (average) on the termination of the experiment,
were kept in fibreglass tanks (1 × 1 × 0.6 m, water depth
40–50 cm) containing running seawater (salinity 32–34 g
L-1) under 24 h light conditions. The water temperature
was between 8–10°C during the experimental period.
During the experiment the fish were fed either a fishmeal
(FM) diet or a diet containing 46% SBM (Table 1) for 1, 3
or 7 days. Prior to the feeding trial the fish were allocated
in the fibreglass tanks and fed the fish meal diet for 27
days. Further details on formulation, chemical composi-
tion and production of the diets are given in [38]. The
experiment was done at AKVAFORSK, The Institute of
Aquaculture Research in Sunndalsøra (Norway).
Long term trial
Farmed Atlantic salmon with an initial weight of approx-
imately 176 g were distributed into fibreglass tanks (1 × 1
× 0.6 m, water depth 40–50 cm) containing running sea
water (5.6°C). The fish were fed either a FM diet or a diet
containing 30% SBM for 3 weeks (Table 1). Before the
start of the trial the salmon were fed a commercial diet
(Skretting AS, Stavanger, Norway). Further details on for-
mulation and chemical composition of the diets as well as
fish and rearing conditions are given in [12]. The experi-
ment was done at AKVAFORSK, The Institute of Aquacul-
ture Research in Sunndalsøra (Norway).
Collection of tissue samples
Fish were randomly selected, anesthetized in tricaine
methansulphate (MS222), weighed, measured and killed
with a sharp blow to the head followed by abdominal
evisceration. The intestines were cleaned of all fatty tissue
and intestinal content prior to collection of samples. The
intestinal regions were defined as follows: the pyloric
intestine (PI) included the intestine with the caeca; the
mid intestine (MI) included the intestine between the
most distal pyloric caecum and the appearance of trans-
verse folds of the luminal surface and the increase in intes-
tinal diameter; the distal intestine (DI) included the
intestine between the distal end of the MI and anus.
For characterization of PAR-2a and PAR-2b mRNA expres-
sion in various tissues 300 mg of the following tissues
were sampled from one fish fed a FM based diet: oesopha-
gus, stomach, pancreas, PI, MI, DI, liver, head kidney, kid-
ney, heart, spleen, thymus, brain, eye, gill, gonads, muscle
and skin. All samples except for pancreas were stored in
RNAlater® (Ambion Inc.) at -20°C until RNA isolation.
Pancreas was collected as follows: approximately 300 mg
of pancreatic tissue, i.e. diffuse pancreas embedded in the
fatty tissue surrounding the pyloric caeca, was gently
scraped off with a spatula and immediately snap frozen in
liquid nitrogen then transferred to ten times the volume
of RNAlater®-ICE (Ambion, Inc.) and stored at -80°C until
RNA isolation.
For quantification of PAR-2 mRNA expression approxi-
mately 300 mg of the DI from the short-term and the
long-term trial was collected and stored on RNAlater®
(Ambion Inc.) at -20°C until RNA isolation. The follow-
ing diets and points of time were collected from the short-
term trial: from the FM group (control fish) 2 fish were
collected on day 1, 3 and 7 respectively (6 in total); from
the SBM group 6 fish were collected at day 1, 3 and 7
respectively (6 fish per day). Nine DI samples were col-
lected from the FM and SBM group respectively in the
long-term trial.
Total RNA extraction
Total RNA was isolated from oesophagus, stomach, pan-
creas, PI, MI, DI, liver, head kidney, kidney, heart, spleen,
thymus, brain, eye, gill, gonads, and muscle using Trizol
(Invitrogen Ltd, Paisley, UK) according to the manufac-
turer's protocol. A modified protocol was used for pan-
creas with three times the volume of reagents.
First strand cDNA synthesis
cDNA was generated from five microgram of total RNA
using PowerScript™ Reverse Transcriptase (BD Bio-
sciences, Franklin Lakes, NJ, USA) according to the manu-
facturer's protocol, primed with a mixture of oligo dT (25
ng/μl) and random hexamer primers (2.5 ng/μl).
Table 1: Diet formulation and composition of the diets, g kg-1.
Short term trial Long term trial
Diet code FM SBM FM SBM
Formulation
Fishmeal 794.6a 322a 700c 490c
Soybean meal - 463b -3 0 0 d
Starch 111 100 - -
Wheat flour - - 144 100
Fish oil 87 109 150 105
Vitamin/mineral premix 7 6 5.0 3.5
Chemical composition (DM)
DM 924 914 935.6 945.6
Lipid 142.5 158.5 248.9 174.2
Crude protein 629.8 465.6 510.9 519.1
Starch 110.3 116.0 - -
Dietary fibre 29.4 110.4 - -
Ash 131.9 81.6 116.3 108.6
aNorsECO (Egersund Sildeoljefabrikk AS, Egersund, Norway).
bDeno-Soy F®, soybean meal with hull that is hexane extracted and 
toasted (Denofa, Fredrikstad, Norway).
cSkretting Australia (Cambridge, TAS, Australia).
dExtruded soybean meal, Skretting Australia (Cambridge, TAS, 
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Cloning and sequencing of PAR-2 mRNA sequences
Multiple DNA sequence alignments was performed from
Homo sapiens [GenBank:NM_005242], Danio rerio [Gen-
Bank:XM_678622],  Hippoglossus hippoglossus [Gen-
Bank:EB034068],  Oncorhynchus mykiss
[GenBank:BX861951] and Xenopus laevis [Gen-
Bank:BX850546] PAR-2 sequences using the publicly
available web browser based bl2seq (Blast 2 Sequences,
[39]). From these alignments we manually designed one
degenerated (PAR-2R_Deg) and one regular PCR primer
(PAR-2F) based on the identification of potential nucleic
acid conservation of PAR-2 sequences. All PCR products
amplified with Advantage 2 PCR enzyme mix (Clontech,
Takara Bio Inc, Shiga, Japan) were used in a post-amplifi-
cation procedure with addition of 2 U of Taq polymerase
(Biotools, B&M Labs, Madrid, Spain) in 1× PCR buffer
(Biotools) for 15 min at 72°C before use in TOPO TA
cloning (TOPO TA Cloning® Kit; Invitrogen, Carlsbad, CA,
USA). The PAR-2 primers and cDNA generated from the
distal intestine were used in PCR amplification using
Advantage 2 PCR enzyme mix (Clontech) in a total reac-
tion volume of 25 μl with the following cycling parame-
ters: 35 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C
for 30 s. A positive PCR product of 149 bp was cloned
using TOPO TA Cloning kit (Invitrogen) according to the
manufacturers' instructions. From the cloning, five clones
were selected and grown for 16 h at 37°C in Luria-Bertani
media containing 50 μg/ml ampicilin. Plasmid DNA was
isolated (E.Z.N.A plasmid miniprep kit I, OMEGA Bio-
Tek, Inc, GA, USA) and sent for sequencing (GATC Bio-
tech, Konstanz, Germany). From the PAR-2 sequence
obtained we manually designed specific PCR primers
unique for each PAR-2 versions for use in 5' and 3' RACE
(rapid amplification of cDNA ends). mRNA was isolated
from total RNA following the manufacturers instructions
(MicroPoly(A)Purist™ Kit, Ambion, Austin, TX, USA), and
approximately 1 μg of was used for reverse transcription
using SMART™ RACE cDNA amplification Kit (Clontech).
The PCR reactions were performed using the Advantage 2
PCR enzyme mix (Clontech) with the following touch-
down PCR setup; 3 min at 94°C followed by: (30 s at
94°C, 3 min at 72°C) × five cycles, (30 s at 94°C, 30 s at
70°C, 3 min at 72°C) × five cycles, (30 s at 94°C, 30 s at
68°C, 3 min at 72°C) × 32 cycles. From each transforma-
tion, 8 clones were selected and grown for 16 h at 37°C in
Luria-Bertani media containing 50 μg/ml ampicilin, plas-
mids were isolated (E.Z.N.A plasmid miniprep Kit I) and
sequenced (GATC Biotech). The sequence chromato-
grams were imported to the free software ContigExpress
(Vector NTI Advance 10, Invitrogen), trimmed for vector
and RACE primer sequences and assembled into contigs.
Quantitative real-time RT-PCR
Total RNA was extracted from DI as previously described.
Prior to reverse transcription, total RNA from all samples
were subjected to DNase treatment using a TURBO DNA-
free™ kit (Ambion) in accordance with the manufacturer's
recommendations.
First strand cDNA synthesis was performed with 0.8 μg
total RNA from each sample using Superscript III (Invitro-
gen) and Oligo(dT)20 primers (Invitrogen) in accordance
with the manufacturer's instructions.
Real-time RT-PCR primers for the two PAR-2 transcripts
were designed based on the full-length sequence using the
free available software FastPCR [40]. Real-time RT-PCR
primers for the housekeeping genes were designed using
Primer3 software [41]. PCR reactions were performed in a
total volume of 10 μl using the LightCycler FastStart DNA
MasterPLUS SYBR GREEN I kit (Roche Diagnostics) using
4.5 μl PCR-grade water, 0.5 μl of each PCR primer (10
μM), 2.5 μl (6.25 ng) cDNA template and 2 μl master mix.
The following program was used: Denaturation (10 min
at 95°C), amplification and quantification program
repeated 40 times (10 sec. at 95°C, 15 sec. at the appro-
priate annealing temperature for the gene specific primers
(Table 2) and 10 sec. at 72°C with a single fluorescence
measurement), melting curve program (60°C to 99°C
with a heating rate of 0.1°C/sec.) and cooling program
down to 40°C.
For determination of the crossing point (CP) the "second
derivative maximum method" measuring maximum
increase rate of newly synthesized DNA per cycle was used
on the basis of the LightCycler software 4.0 (Roche Diag-
nostics). To confirm amplification specificity the PCR
products from each primer pair were subjected to melting
curve analysis and manual inspection of PCR products
after each run by agarose gel electrophoresis.
Relative quantification analyzes
The relative expression ratio of target mRNAs was calcu-
lated using the LightCycler software 4.0 (Roche Diagnos-
tics) with calibrator-normalized relative quantification
and PCR efficiency correction based on a linear regression
fit. RNA from tissues of a fish from the FM group was used
as calibrator. Four reference genes; Elongation factor 1
alpha, Glyceraldehyde-3-phosphate dehydrogenase, 18S
RNA and β-actin (Table 2) were analyzed for stability of
expression in the samples intended for relative quantifica-
tion analyses using the geNorm software [42]. Relative
standard curves were generated on the basis of cDNA
pooled from 2 samples from each diet and sample time,
diluted in 5-fold or 10-fold dilution steps to cover the
expected detection range of the target and housekeeping
genes.Journal of Inflammation 2008, 5:18 http://www.journal-inflammation.com/content/5/1/18
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Phylogenetic analyzes
To examine the evolutionary relationship of the cloned
Atlantic salmon sequences we aligned them with pub-
lished PAR-2 sequences from a set of animal species using
MEGA 4 [43], and used Jalview [44] to visualize the
aligned sequences. The following sequences were used;
human [GenBank:NM_001992, GenBank:NM_005242,
GenBank:NM_004101, GenBank:NM_003950], dog
[GenBank:XM_546059, GenBank:XM_546057, Gen-
Bank:XM_844773, GenBank:XM_541962] mouse [Gen-
Bank:NM_010169, GenBank:NM_007974,
GenBank:NM_010170, GenBank:NM_007975], rat [Gen-
Bank:NM_012950, GenBank:NM_053897, Gen-
Bank:NM_053313, GenBank:NM_053808], zebrafish
[GenBank:XM_694943], frog [GenBank:NM_001085783,
GenBank:NM_001086070]. In MEGA 4 we produced a
cladogram using Neighbor-joining with the following set-
tings; bootstrap = 10000 seed = 38877, complete deletion
for gaps/missing data, Poisson correction for amino acid
substitution and uniform rates among sites.
Statistics
The Shapiro-Wilk W test was used to test conformity with
the normal distribution. Student's t test was used to com-
pare the relative expression of the respective genes
between diets in the three week feed trial. To correct for
multi comparisons of means, analysis of variance was fol-
lowed by Tukey's Honestly Significant Difference (HSD)
test. All results are presented as mean values with bars rep-
resenting SEM. All tests were carried out two-tailed, with a
significance level of 5%. The statistical analyses were per-
formed using JMP 5.0.1 software package (SAS Institute
Inc. Cary, NC, USA).
Results and discussion
Full-length cloning of PAR-2 transcripts
Using cloning and sequencing we identified two full-
length PAR-2 mRNA transcripts termed PAR-2a [Gen-
Bank:FJ184031] and PAR-2b [GenBank:FJ184032] respec-
tively, with 78% nucleic acid identity to each other in the
deduced open reading frame (ORF). The large difference
between the two transcripts indicate that they are likely to
be derived from two genes, probably caused by divergence
of the duplicated genome of Atlantic salmon [45]. Several
expressed genes have previously been shown to be dupli-
cated in Atlantic salmon [46-49], but little is known about
what fraction of the reported duplicated genes are func-
tional. Deduced amino acid similarities of the two PAR-2
receptors were compared to other species by performed
multiple alignments with known PAR-2 sequences from
Homo sapiens and Danio rerio (Figure 1). To visualize the
phylogenetic sequence relations we produced a cladog-
ram using Neighbour joining with BLOSUM62 matrix
(Figure 2). From the alignments and the cladogram, both
deduced Atlantic salmon PAR-2 sequences show similar-
ity to other known PAR-2 sequences. However, the PAR-
2a sequence show more similarity to Danio rerio PAR-2
sequence than to the alternative Atlantic salmon PAR-2b
sequence, which may indicate PAR-2a as the putative
ancestral gene. We also observed considerable differences
in the first 1–45 and 200–229 aa (amino acids) of the two
deduced Atlantic salmon PAR-2 proteins. These regions of
Table 2: PCR primers used in cloning and real-time RT-PCR analysis
Gene name Accession number Primer name PCR primer sequence PCR annealing 
temperature (C°)
PCR product size 
(bp)
PAR-2 - PAR-2F ATCTACATGGCCAACCTGGC 58 149
PAR-2 - PAR-2R_Deg CAGTACAYGTTCCCGTAGAAGAA
PAR-2a - PAR-2a_RACE_F1 GTCCGACCTGCTCTTTGTCATCTGGA 68 1316*
PAR-2a - PAR-2a_RACE_R1 TGGACTCCCCTGAAGATTGCCTACCAC 739*
PAR-2b - PAR-2b_RACE_F1 CTGGACACCTCTGAAGATCGCCTACCAC 1655*
PAR-2b - PAR-2b_RACE_R1 GCCCACCAGGACTTTACACAGCCT 687*
PAR-2a - PAR-2a_RT_F1 GCGCTACTGTGCCATCGTCAA 60 104
PAR-2a - PAR-2a_RT_R1 TGGTCATCAGCCAGACCCCCA
PAR-2b - PAR-2b_RT_F1 ACGCTACTGGGGTGTGGCCCA 104
PAR-2b - PAR-2b_RT_R1 TGGTGGTGAGCCAGATGAAGG
ELF-1 α AF321836 SS-EF1-alpha F1 GTGCTGTGCTTATCGTTGCT 60 148
ELF-1 α AF321836 SS-EF1-alpha R1 GGCTCTGTGGAGTCCATCTT
β-actin AF012125 SS beta-aktin F1 CAAAGCCAACAGGGAGAAGATGA 58 133
β-actin AF012126 SS beta-aktin R1 ACCGGAGTCCATGACGATAC
GAPDH BU693999 GAPDH F1 AAGTGAAGCAGGAGGGTGGAA 60 96
GAPDH BU693999 GAPDH R1 CAGCCTCACCCCATTTGATG
18S rRNA AJ427629 SS-18SrRNA F1 TACAGTGAAACTGCGAATGG 60 153
18S rRNA AJ427629 SS-18SrRNA R1 GCATGGGTTTTGGGTCTG
PAR-2: Proteinase-activated receptor-2, ELF-1 α: Elongation factor 1 alpha, GAPDH: Glyceraldehyde-3-phosphate dehydrogenase. * PCR product 
size after RACE amplificationJournal of Inflammation 2008, 5:18 http://www.journal-inflammation.com/content/5/1/18
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the protein represent the putative N-terminal domain and
extra cellular loop 2 region, both being essential in the
activation of this receptor in mammals. Both deduced
Atlantic salmon PAR-2 protein sequences have a serine
proteinase cleavage site in the N-terminal part of the pro-
tein (Figure 1) in a comparable position of the serine pro-
teinase site in the human PAR-2 protein.
Expression studies of PAR-2 transcripts
Thorough testing of the PCR primer pairs with diluted
plasmid templates for both PAR-2 genes in real-time RT-
PCR experiments showed high specificity for the two PAR-
2 transcripts (data not shown). Expression of both PAR-2
transcripts was seen in all the tissues examined, with
about 10–100 fold higher expression in gills, pyloric-,
mid-, and distal intestine (Figure 3). Our findings are sim-
ilar to reports of high expression of PAR-2 in the colon
and small intestine of man [25,50]. In man, PAR-2 has
been demonstrated to mediate infiltration of leukocytes
as well as hyperreactivity in allergic inflammation of the
airway [23]. Hence, the high expression of the PAR-2
receptor transcripts observed in the gills of Atlantic
salmon could point to analogous functions in the respira-
tory organ of fishes.
Transcription level for PAR-2a showed a rapid and signif-
icant up-regulation at day 1 in fish fed diet with SBM
whereas no expression differences was seen at day 3 or 7
(Figure 4). For PAR-2b there was no significant expression
change during the first 7 days in fish fed diets containing
SBM (Figure 4). Histopathological changes in the distal
intestine of the fish fed the SBM diets showed similar fea-
tures as previously described in another study [3]. No his-
topathological changes were observed after one day of
feeding SBM, and only minor changes in some fish were
seen at day three (results not shown). However, after 7
days most fish displayed the features of SBM induced
enteritis (results not shown). Most fish fed SBM diet for 21
Multiple alignments of deduced PAR-2 amino acid sequences from Atlantic salmon (Ss), zebrafish (Dr) [GenBank:XM_694943]  and human (Hs) [GenBank:NM_005242] visualized using Jalview [44] Figure 1
Multiple alignments of deduced PAR-2 amino acid sequences from Atlantic salmon (Ss), zebrafish (Dr) [Gen-
Bank:XM_694943] and human (Hs) [GenBank:NM_005242] visualized using Jalview 44[44]. The following percentage 
amino acid identity between the compared sequences is indicated with blue color, <40% identity has no color, >40% is light 
blue, >60% is medium dark blue, and >80% is dark blue.Journal of Inflammation 2008, 5:18 http://www.journal-inflammation.com/content/5/1/18
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days displayed fully developed enteritis after histological
investigations as been reported previously [12]. Interest-
ingly, at three weeks feeding a diet containing SBM, a sig-
nificant down-regulation was seen for PAR-2a, and a
significant up-regulation was detected for PAR-2b com-
pared to fish fed the control diet. Even though many
duplicated genes in Atlantic salmon might be classified as
pseudogenes, the observed response for the two PAR-2
genes may suggest involvement of both genes in the SBM
induced enteritis. Overexpression of PAR-2 has been
A cladogram showing the relationship of Atlantic salmon (Salmo salar, in red letters), human (Homo sapiens), dog (Canis famil- iaris), mouse (Mus musculus), rat (Rattus norvegicus), zebrafish (Danio rerio) and frog (Xenopus laevis) proteinase-activated recep- tor 1–4 (PAR-1, PAR-2, PAR-3 and PAR-4) Figure 2
A cladogram showing the relationship of Atlantic salmon (Salmo salar, in red letters), human (Homo sapiens), 
dog (Canis familiaris), mouse (Mus musculus), rat (Rattus norvegicus), zebrafish (Danio rerio) and frog (Xenopus 
laevis) proteinase-activated receptor 1–4 (PAR-1, PAR-2, PAR-3 and PAR-4). The cladogram was created in MEGA 
4 [43] using Neighbor-joining (BLOSUM62 matrix).Journal of Inflammation 2008, 5:18 http://www.journal-inflammation.com/content/5/1/18
Page 8 of 12
(page number not for citation purposes)
Relative expression of PAR-2a (A) and PAR-2b (B) respectively Figure 3
Relative expression of PAR-2a (A) and PAR-2b (B) respectively. Expression levels are relative to muscle tissue sam-
ples. The following tissues were examined; ST: stomach, GI: gills, LI: liver, ES: esophagus, PI: pyloric caeca, MI: mid intestine, DI: 
distal intestine, HK: head-kidney, KI: kidney, SK: skin, MU: muscle, GO: gonads, PA: pancreas, EY: eye, BR: brain, TH: thymus, 
SP: spleen, HE: heart.Journal of Inflammation 2008, 5:18 http://www.journal-inflammation.com/content/5/1/18
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Relative mRNA expression of PAR-2 in the distal intestine of Atlantic salmon Figure 4
Relative mRNA expression of PAR-2 in the distal intestine of Atlantic salmon. The gene expression was normalized 
to both elongation factor 1 α and β-actin, and an average normalized ratio for each individual was calculated. The x-axis repre-
sents days after introduction to SBM and the y-axis represents the normalized ratio. Relative expression of PAR-2a (A) and 
PAR-2b (B) in fish fed fishmeal (FM) (n = 6) day 0 or a diet with inclusion of soybean meal (SBM) at day 1 (n = 6), at day 3 (n = 
6) and at day 7 (n = 6) days. Relative expression of PAR-2a (C) and PAR-2b (D) of fish fed FM diet and diet with inclusion of 
SBM after 3 weeks of feeding. Error bars indicate ± S.E.M (standard error of the mean). Different lower case letters denote sig-
nificant differences (P < 0.05) between the means.Journal of Inflammation 2008, 5:18 http://www.journal-inflammation.com/content/5/1/18
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observed in biopsies from IBD (inflammatory bowels dis-
ease) patients and PAR-2 could play an important role in
the development of colonic inflammation in man [20]. A
pro-inflammatory role for PAR-2 was first shown in the
colon of mice where acute PAR-2 activation led to an
increase in epithelial permeability and bacterial transloca-
tion [17]. Patients with ulcerative colitis treated with a
tryptase inhibitor shown relieved symptoms or remission
of the disease [51], suggesting involvement of PAR-2 and
tryptase in the gastrointestinal disease in these patients.
Luminal proteinases has been demonstrated to regulate
colonic paracellular permeability in mice, and that bacte-
rial flora influences the degranulation of mucosal mast
cells [22]. Further, it was suggested that the increased
expression of PAR-2 observed in colonocytes is influenced
by increased luminal proteinase activity rather than the
release of proteinases such as tryptase [22]. Increased
luminal trypsin-like activity in the distal intestine of
Atlantic salmon fed diets with SBM [11,12] may suggest a
similar mode of PAR-2 activation by serine proteases in
fish.
In mouse colon and small intestine a higher expression of
PAR-2 has been reported in the surface epithelial cells lin-
ing the upper two thirds of the villi compared to cells
located in the crypt region [50]. An increased proliferative
compartment length as well as lower mucosal fold height
have been reported in fish fed SBM feed for three weeks or
more [52]. As a consequence, the observed reduction of
PAR-2a expression after 3 weeks on a SBM diet may be
caused by a reduced number of proliferated cells express-
ing PAR-2 towards the tip of the villi compared to the con-
trol fish. If the two PAR-2 transcripts in Atlantic salmon
are not expressed equally in the same cell populations, the
increased expression of PAR-2b in fish fed SBM feed for 3
weeks might be caused by the number of proliferated cells
or the reported leukocyte infiltrate in fish fed diets con-
taining SBM. The expression profile of the two transcripts
in different cell populations of the intestine needs to be
further investigated.
Recent studies have shown that inflammation of the gut
disrupts the normal microbiota and dramatically boost
colonization of pathogenic bacteria in man [53,54]. An
inflamed gut is therefore an open invitation to several spe-
cies of pathogenic bacteria further promoting the inflam-
mation and a factor in causing disease. The microbiota in
Atlantic salmon changes upon exposure to SBM and a
more diverse population of adherent bacteria has been
reported after 3 weeks feeding a diet containing SBM [52].
The change of PAR-2a expression detected after one day of
exposure to feed containing SBM suggest PAR-2 receptor
activation and could therefore be responsible for an initi-
ation of inflammation. Such an inflammation in concert
with the new feed components could allow colonization
of new bacteria and ultimately changing the normal
microbiota. It is not known however if the microbiota of
Atlantic salmon fed feed containing SBM is altered as early
as one day after feeding, and a putative involvement of
bacteria in the early phases of the development of enteritis
merits further investigation.
The putative role PAR-2 seems to have in intestinal
inflammation in fishes makes it a potential important
marker for enteritis. Soybean meal appears as a promising
tool for studies of PAR-2, intestinal inflammation
responses as well as intestinal cell populations in Atlantic
salmon.
Conclusion
In our study we have demonstrated that Atlantic salmon
have putative duplicated gene versions of the PAR-2 recep-
tor. Both transcripts are highly expressed in the gastroin-
testinal tract and the gills. In Atlantic salmon fed inclusion
levels of SBM the expression of the two PAR-2 transcripts
is altered. We have shown that PAR-2a has a significant
change of expression after one day of feeding diets con-
taining SBM, but that the expression is significantly
decreased in a three week feeding trial. The expression of
PAR-2b did not show altered expression in the first seven
days of feeding but a significant increase in expression is
observed after three weeks. The altered expression of the
two PAR-2 transcripts in the gut of fish fed diets contain-
ing SBM suggests that PAR-2 may have an important role
in inflammation in fishes and other lower vertebrates. The
identification of the PAR-2 genes in Atlantic salmon, a
known initiator of inflammation in the gut of mammals,
opens up for future studies to further shed light on molec-
ular causes of the SBM induced enteritis observed in sal-
monids.
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